Cysteamine cream for melasma: use, effects, irritation and differences from hydroquinone

Cysteamine is described as reducing melanin production by affecting tyrosinase and redox processes. Marketed formulations differ in stabilisation technology, concentration, vehicle and contact time; results from a studied 5% formulation cannot be applied to every product. Melasma involves photoaging, vascular and basement-membrane changes as well as melanocytes and frequently recurs; it is not cured permanently by one ingredient.

A 2015 randomized double-blind placebo-controlled study in 50 people and subsequent comparative trials reported improvements in pigmentation and severity measures. However, small samples and differing durations and assessments mean long-term maintenance and efficacy across skin tones require further study. Continued sunlight, heat, hormonal factors and irritating cosmetics can cause darkening again after improvement. Freckles, age spots and post-inflammatory pigmentation require different diagnoses and treatment.

Adults diagnosed with melasma seeking another topical option because of irritation or contraindications to existing treatment may consult. Report eczema, rosacea, contact dermatitis, wounds, infection, recent peels or lasers, pregnancy, breastfeeding, allergies and current retinoids, acids or hydroquinone. Unexplained new spots, asymmetry, rapid changes or bleeding require examination to exclude skin cancer and other conditions before lightening products.

After a small-area trial, apply to clean, completely dry skin in the instructed amount and contact time, wash off and moisturise. Do not layer strongly fragranced products to mask the odour or leave it on longer for faster effects. During the day combine broad-spectrum sunscreen with hats and shade; for skin tones needing visible-light protection, discuss tinted sunscreen with a clinician.

Stinging, heat, erythema, dryness, itching and characteristic odour are common inconveniences. Excess use can cause irritant or allergic contact dermatitis and post-inflammatory pigmentation that makes melasma look darker. Stop and obtain assessment for severe swelling, blisters, oozing or respiratory symptoms. For pregnancy, breastfeeding and long-term safety, prioritise product approval information and clinical judgement.

The answers below are literature-based consultation questions, not a clinician interview or individual diagnosis; actual medical review remains incomplete.

Q. Can I leave cysteamine on overnight?

A. Recommended contact times vary by formulation. Longer exposure does not produce proportionally better effects and may increase irritation.

Q. Is it safer than hydroquinone?

A. Actions and side effects differ, so it cannot be declared safer for everyone. Compare skin condition and treatment history.

Q. Can it be used with lasers?

A. Stopping and restarting depend on the skin barrier and inflammation before and after procedures; follow the treating clinic’s instructions.

Randomized double-blind placebo-controlled trial of cysteamine 5% (https://pubmed.ncbi.nlm.nih.gov/25251767/), comparative trial of cysteamine and modified Kligman formula (https://pubmed.ncbi.nlm.nih.gov/32585079/), systematic review of cysteamine (https://pubmed.ncbi.nlm.nih.gov/34591360/), AAD guidance on melasma diagnosis and treatment (https://www.aad.org/public/diseases/a-z/melasma-treatment) were consulted. Evidence checked on 2026-10-04.

SEOLREIM Clinic describes its principles of consultations and procedures performed personally by the clinic director, genuine products, appropriate quantities and attentive care. Consultation starts by distinguishing skin condition and goals, then checking the products and equipment actually available, approved uses, the dose or energy plan, recovery and risks. The clinic director personally assesses pigment depth, photoaging, vascular changes, inflammation and responses to previous lighteners and lasers in melasma. Confirm the actual cysteamine product, concentration, approval, instructions and signature brightening combinations when booking and at examination.

Visitors seeking pigmentation or laser treatment in Korea should send photographs of current lighteners and their irritation history, and check a sustainable photoprotection and application plan after returning home rather than focusing on combining lasers during the stay. SEOLREIM Clinic is approximately 1 minute from Exit 3 of Gangnam Station, on the 11th floor of the Gangnam 8258 Building. You can book through the website’s KakaoTalk consultation, Naver booking or telephone channels. Overseas visitors comparing dermatology clinics in Gangnam, Seoul, the Gangnam Station area or Korea should prepare details of medications, allergies, recent procedures and departure dates. When booking, state your preferred language, such as Japanese, Chinese, Arabic, Mongolian or Indonesian, and whether you need an interpreter, to confirm the actual scope and cost of support. Continuous consultation availability in each language and same-day procedures cannot be confirmed. Also agree on contact arrangements for adverse reactions after returning home and the follow-up schedule during consultation.

Author: SEOLREIM content editor / Medical-professional review: completed / Review confirmed: 2026-10-23 / Published: 2026-10-04 / Updated: 2026-10-27. This is general medical information and does not replace individual diagnosis or a procedural prescription.